Bots, editor, reviewer, Administrators
13,951
edits
Feed:Trial Acronyms: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 212: | Line 212: | ||
"ESPRIT" : "European/Australasian Stroke Prevention in Reversible Ischaemia Trial", | "ESPRIT" : "European/Australasian Stroke Prevention in Reversible Ischaemia Trial", | ||
"ATHOS-3" : "Angiotensin II for the Treatment of High-Output Shock", | "ATHOS-3" : "Angiotensin II for the Treatment of High-Output Shock", | ||
"ARISTOTLE" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation", | "ARISTOTLE" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation", | ||
"PROWESS" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis", | "PROWESS" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis", | ||
| Line 235: | Line 234: | ||
"IABP-SHOCK II" : "Intraaortic Balloon Pump in Cardiogenic Shock II", | "IABP-SHOCK II" : "Intraaortic Balloon Pump in Cardiogenic Shock II", | ||
"PARTNER 2" : "Placement of Aortic Transcatheter Valves, Cohort A", | "PARTNER 2" : "Placement of Aortic Transcatheter Valves, Cohort A", | ||
"LoDoCo" : "Low-Dose Colchicine", | "LoDoCo" : "Low-Dose Colchicine", | ||
"CHAMPION PHOENIX" : "Cangrelor versus standard therapy to achieve optimal management of platelet inhibition", | "CHAMPION PHOENIX" : "Cangrelor versus standard therapy to achieve optimal management of platelet inhibition", | ||
| Line 328: | Line 326: | ||
"HPTN 052" : "HIV Prevention Trials Network 052 Study", | "HPTN 052" : "HIV Prevention Trials Network 052 Study", | ||
"SURTAVI" : "Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement", | "SURTAVI" : "Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement", | ||
"EMPHASIS-HF" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure", | "EMPHASIS-HF" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure", | ||
"POISE" : "PeriOperative ISchemic Evaluation", | "POISE" : "PeriOperative ISchemic Evaluation", | ||